- BNF:
- not listed
- Status:
- Grey
- Decision Date:
- December 2016
Comments
GREY: For the treatment of recurrent bacterial vaginosis, as a second line option after treatment failure and or intolerance to metronidazole.
Grey Drug Classifications
- 1: Lack of data on effectiveness compared with standard therapy
- 5: Less cost-effective than current standard therapy
search again